Razdan, Rishi N.
Rosenblatt, Melvin
Jiao, Yue
McLaughlin, Nancy
Usvyat, Len A.
Sor, Murat
Larkin, John W.
Article History
Received: 15 September 2021
Accepted: 8 March 2022
First Online: 18 March 2022
Declarations
:
: This analysis was conducted under a protocol that was reviewed and approved by New England Independent Review Board (IRB) (Needham Heights, MA, United States; NEIRB#WO-1-574-1). The IRB approved the protocol under an Exempt Category since the analysis used deidentified patient data that did not include Protected Health Information and written/verbal informed consent was not required nor applicable per the Code of Federal Regulations (45CFR46) in the United States. This study adhered with the Declaration of Helsinki.
: Not applicable.
: All authors are employees of Fresenius Medical Care, or its subsidiary company Azura Vascular Care. L.A.U. has share options/ownership in Fresenius Medical Care. L.A.U., J.W.L. are an inventor on patent(s) in the field of dialysis. J.W.L. is a guest editor on the Editorial Board of Frontiers in Physiology.